Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

China Biotech Week In Review: Roche's China Strategy
Seeking Alpha
Sunday, November 6, 2011 - 12:43pm
tags:
Roche, China National Biotechnology Group, Aslan, Alios BioPharma, ImmunoBiology Ltd, Healthgen Biotechnology
Investors sue KV Pharmaceutical, alleging misleading statements
STL Today, MO
Sunday, November 6, 2011 - 12:39pm
tags:
KV Pharmaceutical, lawsuits
Biogen-Idec's BG-12 Shines At the Top of the Charts in the Treatment of Relapsing-Remitting Multiple Sclerosis
Bradenton Herald, FL
Sunday, November 6, 2011 - 12:28pm
tags:
Biogen, BG-12, multiple sclerosis, Teva Pharmaceuticals, Copaxone, CONFIRM
Roche Unit Didn't Follow Procedures To Prevent Drug Contamination; Galena Presents Positive NeuVax Clinical Results
Biomed Reports
Sunday, November 6, 2011 - 12:25pm
tags:
Roche, Avastin, Galena Biopharma, NeuVax, breast cancer
Presidio Pharmaceuticals, Inc. Announces Clinical Proof-of-Concept Data for its First HCV NS5A Inhibitor, PPI-461, and Initiation of Clinical Testing for its Second-Generation NS5A Inhibitor, PPI-668.
BusinessWire
Sunday, November 6, 2011 - 12:19pm
tags:
NS5A Inhibitors, PPI-461, PPI-668, HCV
Adamis Pharmaceuticals Corp. (ADMP) is “One to Watch”
Beacon Equity Research
Sunday, November 6, 2011 - 12:14pm
tags:
Adamis Pharmaceuticals, TeloB-VAX, prostate cancer, cancer vaccines
9 Biotech Stocks Being Snapped Up By Company Insiders
Seeking Alpha
Sunday, November 6, 2011 - 12:06pm
tags:
Complete Genomics, Theravance, Ziopharm, Threshold Pharmaceuticals, Repros Therapeutics, MannKind, PharmAthene, Seattle Genetics, Corcept Therapeutics
Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease
Yahoo/PR NewsWire
Sunday, November 6, 2011 - 12:01pm
tags:
Enbrel, Amgen, rheumatoid arthritis
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Yahoo/PR NewsWire
Sunday, November 6, 2011 - 12:00pm
tags:
Prolia, osteoporosis, Amgen
Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis
Yahoo/BusinessWire
Sunday, November 6, 2011 - 11:59am
tags:
Vertex Pharmaceuticals, JAK3 inhibitors, VX-509, rheumatoid arthritis
Inhibitex Investors: Why Shares Popped 115%
Motley Fool
Sunday, November 6, 2011 - 11:57am
tags:
Inhibitex, INX-189, hepatitis C
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
Yahoo/PR NewsWire
Saturday, November 5, 2011 - 2:49pm
tags:
Savient, Krystexxa, gout
Interim Data from Phase 2 Study Showed 93% of People with Hepatitis C Who Received a Total of 12 Weeks of a Combination Regimen Including INCIVEK™ (telaprevir) and VX-222 (400mg) Achieved a Viral Cure (SVR)
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:48pm
tags:
VX-222, Incivek, Vertex Pharmaceuticals
Positive Interim Data From a Phase 2 Study of INCIVEK™ (telaprevir) Combination Therapy in People Co-Infected with Hepatitis C and HIV Presented at The Liver Meeting®
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:47pm
tags:
Incivek, Vertex Pharmaceuticals, hepatitis C, HIV
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:46pm
tags:
Viread, Gilead Sciences, hepatitis B
Sequenom CEO Discusses Q3 2011 Results - Earnings Call Transcript
Seeking Alpha
Saturday, November 5, 2011 - 2:45pm
tags:
Sequenom
You Should Have Seen These Biotech Failures Coming
Motley Fool
Saturday, November 5, 2011 - 2:44pm
tags:
Oxigene, Rexahn
Illumina Shares Jumped: What You Need to Know
Motley Fool
Saturday, November 5, 2011 - 2:42pm
tags:
Illumina, genomics
Vical Back On The Move
Seeking Alpha
Saturday, November 5, 2011 - 2:37pm
tags:
Vical
Idera Pharmaceuticals Completes $9.5 Million Financing
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:36pm
tags:
Idera Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.